Angiodynamics (ANGO) Retained Earnings (2011 - 2026)

Angiodynamics has reported Retained Earnings for 16 years, with the latest figure at -$454.5 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 12769.03% year-over-year to -$454.5 million; the trailing twelve-month figure through Feb 2026 stood at -$454.5 million (down 12769.03% YoY), and the FY2025 full-year result was -$429.2 million, down 9732.69% from the prior year.
• Retained Earnings for Q1 2026 stood at -$454.5 million, down from -$446.4 million in the prior quarter.
• The five-year high for Retained Earnings was $1.4 million in Q2 2022, with the low at -$454.5 million in Q1 2026.
• Historically, Retained Earnings has averaged -$216.7 million across 5 years, with a median of -$179.9 million in 2022.
• Annual changes were most pronounced in 2023 — Retained Earnings sank 20542.5% — and 2025, when it jumped 99.07%.
• Angiodynamics' Retained Earnings stood at -$179.9 million in 2022, then dropped by 7.85% to -$194.0 million in 2023, then tumbled by 115.82% to -$418.7 million in 2024, then retreated by 6.62% to -$446.4 million in 2025, then dropped by 1.81% to -$454.5 million in 2026.
• The last three Retained Earnings figures came in at -$454.5 million (Q1 2026), -$446.4 million (Q4 2025), and -$440.1 million (Q3 2025), per Business Quant data.